[go: up one dir, main page]

DK0468875T3 - Self-adhesive matrix system for extended release of piribedil by transcutaneous pathway - Google Patents

Self-adhesive matrix system for extended release of piribedil by transcutaneous pathway

Info

Publication number
DK0468875T3
DK0468875T3 DK91402036.7T DK91402036T DK0468875T3 DK 0468875 T3 DK0468875 T3 DK 0468875T3 DK 91402036 T DK91402036 T DK 91402036T DK 0468875 T3 DK0468875 T3 DK 0468875T3
Authority
DK
Denmark
Prior art keywords
piribedil
self
matrix system
extended release
adhesive matrix
Prior art date
Application number
DK91402036.7T
Other languages
Danish (da)
Inventor
Alain Cuine
Jean-Marc Rollot
Isabelle Rault
Francoise Arnaud
Yvonne Evrard
Claire Chezaubernard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0468875T3 publication Critical patent/DK0468875T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention relates to a self-adhesive silicone elastomer matrix system for the sustained release of piribedil, which provides for the continuous and steady transdermal diffusion of piribedil.
DK91402036.7T 1990-07-23 1991-07-23 Self-adhesive matrix system for extended release of piribedil by transcutaneous pathway DK0468875T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9009361A FR2664815B1 (en) 1990-07-23 1990-07-23 SELF-ADHESIVE MATRIX SYSTEM FOR THE EXTENDED RELEASE OF THE PIRIBEDIL BY TRANSCUTANEOUS ROUTE.

Publications (1)

Publication Number Publication Date
DK0468875T3 true DK0468875T3 (en) 1995-11-20

Family

ID=9398984

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91402036.7T DK0468875T3 (en) 1990-07-23 1991-07-23 Self-adhesive matrix system for extended release of piribedil by transcutaneous pathway

Country Status (15)

Country Link
EP (1) EP0468875B1 (en)
JP (1) JPH04234322A (en)
AT (1) ATE124271T1 (en)
AU (1) AU635653B2 (en)
CA (1) CA2047508A1 (en)
DE (1) DE69110781T2 (en)
DK (1) DK0468875T3 (en)
ES (1) ES2075942T3 (en)
FR (1) FR2664815B1 (en)
GR (1) GR3017276T3 (en)
IE (1) IE912577A1 (en)
NZ (1) NZ239074A (en)
OA (1) OA09384A (en)
PT (1) PT98416B (en)
ZA (1) ZA915769B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2675383B1 (en) * 1991-04-18 1995-05-12 Bernard Aranda USE OF A MEDICINAL PRODUCT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HYPERACTIVE OR UNSTABLE BLADDER.
FR2691361B1 (en) 1992-05-19 1994-07-08 Adir SELF-ADHESIVE MATRIX SYSTEM FOR THE EXTENDED RELEASE OF THE PIRIBEDIL BY TRANSCUTANEOUS ROUTE.
DE19512181C2 (en) * 1995-03-31 2003-11-06 Hexal Pharma Gmbh Transdermal system with ramipril and / or trandolapril as an ACE inhibitor
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
ID30353A (en) * 1999-02-05 2001-11-22 Cipla Ltd TOPICAL SPRAY MEDICINE
RU2358699C2 (en) 2001-06-18 2009-06-20 Ноувен Фамэсьютикэлз, Инк. Percutaneous drug delivery composition (versions), method of production and application
US6805878B2 (en) 2001-09-13 2004-10-19 Noven Pharmaceuticals, Inc. Transdermal administration of ACE inhibitors
CN105267173A (en) * 2014-05-30 2016-01-27 北京星昊医药股份有限公司 Piribedil sustained-release tablets and preparation method thereof
WO2016069898A1 (en) * 2014-10-30 2016-05-06 Textile-Based Delivery, Inc. Delivery systems
CN105232475A (en) * 2015-11-19 2016-01-13 哈尔滨圣吉药业股份有限公司 A kind of piribedil sustained-release pellets and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2519986A1 (en) * 1982-01-21 1983-07-22 Adir NOVEL BENZODIOXINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
DE3344691A1 (en) * 1983-12-10 1985-06-20 Bayer Ag, 5090 Leverkusen ACTIVE GAS EXHAUST SYSTEMS
EP0196769B1 (en) * 1985-02-25 1992-07-08 Rutgers, The State University of New Jersey A novel transdermal pharmaceutical absorption dosage unit
HU197519B (en) * 1987-06-22 1989-04-28 Biogal Gyogyszergyar Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade
FR2619388A1 (en) * 1987-08-14 1989-02-17 Rhone Poulenc Chimie SOFT LAMINATE ARTICLE FOR TRANSFER ADHESIVE

Also Published As

Publication number Publication date
DE69110781T2 (en) 1995-11-23
ES2075942T3 (en) 1995-10-16
AU635653B2 (en) 1993-03-25
NZ239074A (en) 1992-10-28
EP0468875A3 (en) 1992-04-01
CA2047508A1 (en) 1992-01-24
IE912577A1 (en) 1992-01-29
FR2664815A1 (en) 1992-01-24
JPH04234322A (en) 1992-08-24
PT98416B (en) 1999-01-29
EP0468875B1 (en) 1995-06-28
PT98416A (en) 1994-01-31
FR2664815B1 (en) 1994-11-04
GR3017276T3 (en) 1995-11-30
ATE124271T1 (en) 1995-07-15
DE69110781D1 (en) 1995-08-03
AU8121391A (en) 1992-01-30
ZA915769B (en) 1992-05-27
EP0468875A2 (en) 1992-01-29
OA09384A (en) 1992-09-15

Similar Documents

Publication Publication Date Title
ATE205706T1 (en) ACTIVE PLASTERS
NZ217844A (en) A sustained release pharmaceutical composition containing silicone elastomer and an albumin
DK0450141T4 (en) Carrier for administering drugs
DK0767798T3 (en) Sterol derivatives used to control meiosis
DK147988A (en) HEARING EQUIPMENT, NECESSARY FOR EQUIPMENT
DE69113205D1 (en) Transdermal therapeutic system.
FR2688404B1 (en) DEVICE FOR HYDRAULIC REGULATION OF THE WALKING OF FEMALE AMPUTES.
ES2184127T3 (en) DERIVATIVES OF USEFUL ANTI-CONVULSIVE SULFAMATE FOR THE TREATMENT OF OBESITY.
ES2195970T3 (en) L-RIBAVIRINA AND USES OF THE SAME.
FI921281A7 (en) Solvent-free or high-solids pressure-sensitive silicone adhesive formulations
DE68910254D1 (en) Low-viscosity, pressure-sensitive, elastomeric adhesive based on siloxanes.
TR199701146T1 (en) 1-Phenylpyrazole-3-Carboxamides acting on neurotensin receptors.
NO974321D0 (en) Nodulisporsyrederivater
DK0468875T3 (en) Self-adhesive matrix system for extended release of piribedil by transcutaneous pathway
DK0639275T3 (en) Novel GABAα receptor subtypes and methods for screening drug compounds using imidazoquinoxalins and pyrrolopyimidines for binding to GABAα receptor subtypes
FI912654L (en) SYSTEM FOER ATT SORTERA SMAO PRODUKTSTYCKEN SOM KLIPPTS UR ARBETSSKIVOR.
DK0662837T3 (en) Use of IL-10 to prevent insulin-dependent diabetes mellitus
PT87244A (en) REZEPTOR DER KLEINEN RHINOVIRUS REZEPTOR GRUPPE
ES2101936T3 (en) OXAMIDIC STABILIZERS.
DK101197A (en) Drug for the treatment of thrombocytopenia
DK0456792T3 (en) Improved transdermal system for administration of pharmacologically active compounds under pH controlled conditions
ES2062794T3 (en) DERIVATIVES OF (ALKYLTIO-3 PROPIL) -3 BENZOTIAZOLINE, ITS PREPARATION AND THE MEDICINES THAT CONTAIN THEM.
ES2127259T3 (en) PIRIBEDIL PROLONGED RELEASE SYSTEM.
DK1107779T3 (en) Drugs for Minipulation of T-Cell Immune Response
ATE81002T1 (en) DELAYED-RELEASE FIXED DRUG COMBINATION.